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Abstract: 20 
During the last two decades our understanding of the complex in vivo host-pathogen interactions has 
increased due to technical improvements and new research tools. The rapid advancement of molecular 
biology, flow cytometry and microscopy techniques, combined with mathematical modelling, have 
empowered in-depth studies of systemic bacterial infections across scales from single molecules, to 
cells, to organs and systems to reach the whole organism level. By tracking subpopulations of bacteria 25 
in vivo using molecular or fluorescent tags, it has been possible to reconstruct the spread of infection 
within and between organs, allowing unprecedented quantification of the effects of antimicrobial 
treatment and vaccination. This review illustrates recent advances in the study of heterogeneous traits 
of the infection process and illustrate approaches to investigate the reciprocal interactions between 
antimicrobial treatments, bacterial growth/death as well as inter- and intra-organ spread. We also 30 
discuss how vaccines impact the in vivo behaviour of bacteria and how these findings can guide 
vaccine design and rational antimicrobial treatment. 
 
Highlights:  
• Isogenic tagging, fluorescent growth reporters, single cell flow cytometry and advanced 35 
microscopy techniques have empowered in-depth studies of systemic bacterial infections from 
single cells to whole organism level.  
• The full picture of the complex infection processes has been gained by analysis of 
experimental results with the help of appropriate mathematical models. 
• Use of those approaches enabled to investigate the population dynamics under and upon 40 
cessation of antimicrobial treatments, and to guide vaccine treatment. 
 
  
1. Salmonella enterica as model for the discovery of new methods and approaches to study 
population dynamics during systemic infection 45 
Despite improvements of hygienic conditions and in some cases the availability of effective 
antimicrobials and vaccines, bacterial diseases still pose a threat for humankind causing about six 
million deaths per year (MacLennan and Saul, 2014). Biological and clinical research has started to 
unravel the complex behaviour of bacteria during infections and their reaction to treatments, from 
the level of the whole animal organism down to single cells. Pathogens show higher phenotypic 50 
heterogeneity in the tissues of infected hosts compared to laboratory cultures, including bacterial 
growth rates, aggregation state, metabolism and stress responses (Bottery et al., 2019, Duneau et al., 
2017, Gjini and Brito, 2016, Grant et al., 2008, Kolter et al., 1993, Shehata and Marr, 1971). This 
is, at least in part, due to the diverse microenvironments where individual bacteria reside at different 
times of the infection process, leading to their exposure to a variety of host cell types, immune 55 
mediators (e.g. cytokines) and cellular antimicrobial metabolites.  
Systemic Salmonella enterica infections are widespread and cause diseases in humans and other 
animals. Typhoid fever, paratyphoid fever (Crump, 2012, Crump and Mintz, 2010) and invasive non-
typhoidal salmonellosis (Crump et al., 2015, Kariuki et al., 2015)), have been the topic of extensive 
research, providing a paradigm for other diseases where the bacteria that have both intracellular and 60 
extracellular phases in their lifecycle. The availability of robust in vivo murine models of systemic 
Salmonella infection, coupled with the possibility to genetically manipulate both the pathogen and 
the host, allows experimentation within the complexity and biological relevance of a whole 
mammalian organism. The integration of several methods, described in this article, applied to this 
host-pathogen combination has provided an understanding of immunity, treatment, and vaccine 65 
design in humans and other animals.  
 
2. The interplay between bacteria and the host in vivo: population dynamics and the 
importance of bottlenecks 
Several variables determine the course and outcome of an infection process. These include, amongst 70 
others, the genetic makeup and immune status of the host, the level of virulence of the bacterium and 
the infecting dose. Bacteria are exposed to constrains posed by the host, and combinations of host 
and bacterial factors determine the progression of the disease.   
Recent methods for the study of infection in vivo have enabled the mapping of 
spatiotemporal population dynamics of bacteria during an infection with unprecedented resolution. 75 
This has added details to our knowledge of how vaccines and antimicrobial treatments impact on the 
infection process often via the generation of “bottleneck events”.  
Bottlenecks are constraints that may lead to reductions in the bacterial population size and/or may 
mechanistically or stochastically select bacterial subpopulations. Bottlenecks can be caused by 
anatomical barriers, immunological mechanisms, antimicrobials or vaccine-induced enhancements in 80 
host resistance. Unless they determine a marked reduction in the size of the overall viable bacterial 
population, bottlenecks can be difficult to detect because they can be followed by a phase of 
exponential expansion of surviving bacteria that are no longer inhibited by the original constraint. 
Surviving post-bottleneck populations may have a similar or a markedly different population structure 
compared to the pre-bottleneck ones, depending on the type and size of the bottleneck. Wide 85 
bottlenecks may cause only minor changes in the population size and structure of the bacteria 
composing the pre-bottleneck population. Tight bottlenecks can lead to situations where the pre-
bottleneck bacterial sub-populations are differentially reduced or even lost, resulting in surviving 
populations that can be different from the ones present at the beginning of the infection process or in 
the pre-bottleneck phase/location. 90 
In summary, canonical approaches for measuring pathogen loads in vivo (post-mortem bacterial 
enumeration) are not ideal to detect bottlenecks when there is no contraction of the overall bacterial 
population size; these unrefined approaches do not capture changes in the inherent heterogeneity of 
the in vivo bacterial loads within an organ or at the whole animal level. Therefore, analyses that allow 
tracking of individual bacterial subpopulations need to be used to gain a full picture of how the 95 
intertwined interactions between the pathogen and the host impact on the within-host evolution of the 
infection process.   
 
3. Techniques to track bacterial subpopulations and their growth status in vivo 
Capitalising on technological advances, four experimental approaches have shown great promise for 100 
studying processes of within-host population dynamics that cannot be directly observed by traditional 
methods: isogenic tagging, advanced microscopy, single-cell flow cytometry, and fluorescent growth 
reporters (Figure 1).  
 
 105 
Figure 1. Techniques to track and reconstruct population dynamics at single cell level within a whole 
experimental animal. 
 
3.1 Isogenic tagging - Bottlenecks in bacterial infections can be inferred by determining changes 
between different time-points of mixes of isogenic tagged strains (ITS) that contain inheritable 110 
distinguishable markers. These are usually specific nucleotide sequences (tags) inserted in a non-
coding region of the chromosome. It is essential that the tags do not alter pathogen fitness (Grant, et 
al., 2008), and are uniquely detectable to allow the quantification and tracking of each tagged 
subpopulation in vivo. The relative frequencies of ITS within a bacterial population can be measured 
by quantitative PCR (Grant, et al., 2008) or sequencing of the tagged region (Rossi et al., 2017). 115 
Earlier implementations of this approach using genetic variants that could be identified by culture on 
selective media (with different substrates (Meynell and Stocker, 1957) or antibiotics (Moxon and 
Murphy, 1978)) suffered from both a lack of control of fitness differences in vivo and strict limitations 
in the number of strains that could be used simultaneously in an experiment.  In contrast, the use of 
multiplex PCR or sequencing allows the monitoring of unlimited number of ITS (Abel et al., 2015, 120 
Abel et al., 2015, Schwartz et al., 2011).  
Presence, absence and relative proportions of ITS in different organs, together with the absolute 
number of viable bacteria, can be monitored at different stages of experimental infections and 
treatment. This approach, combined with mathematical analyses (see below) allows to infer not just 
bottlenecks, but also spatiotemporal variations in the rates at which bacteria divide, die and disperse 125 
in multiple organs and to identify differences in behaviour of the bacterial population at different 
stages of the infection and/or treatment process. For example, increases in heterogeneity within a 
particular anatomical site are considered as an indication of amplification and/or preferential selection 
of a restricted number of bacterial subpopulations; reductions in heterogeneity between two different 
anatomical sites can reveal the transfer of bacteria between the two sites. Bacterial death rates can be 130 
estimated from the disappearance coupled with absolute load decrease of ITS through time, and 
growth by the appearance and relative increase of different ITS through time (Grant, et al., 2008). 
Similarly, the loss of some of the ITS in a defined population would indicate that a certain proportion 
of bacteria have died and/or have been replaced by replication of some other subpopulation (Figure 
1, top left panel). 135 
 
3.2 Advanced microscopy techniques - Multicolour fluorescence microscopy (MCFM) and confocal 
microscopy have been used to gather information on the location of the bacteria in the tissues, to 
identify and characterise the sites and the cells where Salmonella is found and to determine the 
number of bacteria within each infected cell (Grant et al., 2012). This enables to determine the intra- 140 
versus extra-cellular location of the bacteria, their association with inflammatory multicellular 
pathological lesions (Sheppard et al., 2003), as well as the location and cell surface markers of the 
infected cells in tissue samples. This is achieved by staining with fluorescently marked antibodies 
specific for host cell markers and/or bacteria (Sheppard, et al., 2003), and/or using bacteria engineered 
to express fluorochromes (e.g. GFP) (Rollenhagen et al., 2004). However, in some phases of infection 145 
or treatment (e.g. after prolonged antimicrobial treatment) low (e.g. less than 1000 bacteria per organ) 
bacterial numbers in the organs would require observation of impractically large volumes of tissue to 
visualize sparse bacterial populations (Rossi, et al., 2017). Nowadays, more advanced technologies 
are available for detecting low bacterial numbers in tissues. For example, the Opera Phenix High-
Content Screening fluorescence/confocal system with the Harmony high-content analysis software 150 
performs fully automated scans of large numbers of tissue sections and multicolour image acquisition, 
with the option of intelligent image analysis and higher magnification/resolution re-scan (Fraietta and 
Gasparri, 2016).  
To overcome the need for culling of experimental animals at each time point before sampling, 
luminescent imaging can be also used to directly detect emitted photons from lux-expressing 155 
Salmonella in live anesthetized mice and therefore follow the course of infection in various organs. 
However, bioluminescence approaches lack sensitivity and resolution, with a minimum of hundreds 
of bacteria clustered together being required to obtain detectable signals in vitro (without the added 
loss of signals due to skin and tissue), thus limiting the possibility of quantifying the dynamics of 
small subpopulations of bacteria in vivo (Avci et al., 2018). 160 
Expansion microscopy is another powerful technique to detect bacteria in small organs (e.g. lymph 
nodes) or in specific phases in which their overall number is low. This technique relies on the 
expansion of small structures using an isotropic polymer system (and clarification of the organs if 
necessary to reduce autofluorescence), still maintaining the same nanoscale detail of the organ. The 
expanded structure can be then visualized at the same level of detail with a lower magnification. In 165 
other words, expansion microscopy enables high-resolution imaging on a conventional light 
microscope (Lim et al., 2019). Another interesting and novel technique is represented by super-
resolution stochastic optical reconstruction microscopy (STORM)–correlative light electron 
microscopy (CLEM); this allows bacteria to be imaged within host cells with a resolution of 20 nm 
(van Elsland et al., 2018). 170 
In parallel to advancements in the resolution of microscopy techniques, algorithms are continuously 
developed (e.g. Harmony software of Opera Phoenix) to map the spatial location of sparse bacterial 
populations and to initiate high-resolution imaging protocols via confocal, two-photon and 
structured-illumination microscopy in situ, thus automatizing the microscopy systems (Figure 1, top 
right panel). 175 
 
3.3. Single cell flow cytometry - Global genomic, proteomic and transcriptional profiling can be 
nowadays performed at the single-cell level (Mosser and Edwards, 2008, Saliba et al., 2016, 
Westermann et al., 2012) after FACS-sorting the cells of interest. This enables to study the 
heterogeneity of individual microbe-host cell interactions during infection. For example, combining 180 
FACS-sorting of infected cells with single-cell RNA sequencing has revealed that macrophages 
infected by non-growing bacteria display a pro-inflammatory M1 state, whereas macrophages 
containing fast-growing bacteria were predominantly in an anti-inflammatory M2 state (Saliba, et al., 
2016). This is an important finding that reveals how heterogeneity in pathogen behaviour is 
intertwined and possibly determines heterogeneity in the phenotype of the infected host cell.    185 
Single cell flow cytometry enables to compare the level and type of specific markers in different 
organs, at different stages of treatment or infection, or to compare the phenotype of infected and non-
infected cells. Furthermore, simultaneous determination of the transcriptomic profile (dual RNA-seq) 
of both bacteria and the host (Stapels et al., 2018, Westermann et al., 2016) can provide information 
about the interface between bacteria and host (Oshota et al., 2017). The main drawbacks of these 190 
techniques are the cost, the amount of data generated, and sometimes the lack of specific behaviour 
in the context of the whole organ/organism (Figure 1, bottom right panel). 
3.4 Fluorescent growth reporters - Single-cell fluorescent growth reporters (Helaine et al., 2010) 
have been successfully used to measure bacterial division rates in vivo, and reveal the presence of 
distinct Salmonella subsets with divergent division rates in different tissues. Here we outline two 195 
methods that differ in the information they provide: i) Fluorescence Dilution (FD) analysis tracks the 
number of generations since the start of infection; ii) the TIMER reporter reveals the recent rate of 
division at the time of harvesting. 
FD analysis (Helaine et al., 2014, Helaine and Holden, 2013, Helaine, et al., 2010) is used to detect 
bacteria that have not divided or that have undergone a limited number of divisions from the 200 
beginning of the infection to the time of observation. This can be done exploiting fluorescent proteins 
that are produced only in the presence of inducers (e.g. arabinose or  IPTG); when the bacteria 
replicate in the absence of the inducer (e.g. arabinose), a rapid decrease in signal (“dilution”) of the 
preformed pool of fluorescent protein is observed. Therefore, the measurement (e.g. by FACS) of 
reduction of fluorescence intensity over time is a proxy of the number of replications undergone by 205 
the bacterium. Hence, bacteria with low and high fluorescence respectively represent cells that have 
undergone multiple or no/few rounds of cell division (Helaine, et al., 2010).  
TIMER (DSredS197T) protein spontaneously changes fluorescence colour (e.g. emission spectra) 
from green to orange over time. Although the complex atomic and molecular underlying processes  
are not fully understood, variations in colour of fluorescence can be accurately calibrated to measure 210 
the current division rate of bacteria at the time of observation (Claudi et al., 2014). In cells that have 
recently undergone cell division, the fast maturing green TIMER molecules are more abundant 
compared to slowly maturing orange TIMER molecules, resulting in a dominant green fluorescence 
(Claudi, et al., 2014). In contrast, in non-proliferating cells, the slowly maturing orange TIMER 
molecules accumulate, yielding a characteristic green/orange fluorescence.  215 
A major strength of both FD and TIMER markers is that they can be used at the single-cell level to 
reveal phenotypic heterogeneity, either by microscopy or by flow cytometry (FACS). FACS also 
allows to sort single host cells based on the growth reporter or other markers, and their transcriptional 
profile can then be determined by scRNA-seq (Saliba, et al., 2016). Both FD and TIMER have been 
used in vivo to study the growth history of Salmonella during antimicrobial treatment. This has 220 
revealed that non-replicating Salmonella survive exposure to antibiotics better than fast-dividing 
bacteria. However, non-replicating bacteria are normally a minority of the overall population in the 
organ and therefore the most abundant population that remains in the tissues after treatment consists 
of  partially antibiotic-tolerant, moderately-growing bacteria (Claudi, et al., 2014). Additional 
applications for FD or TIMER are their combination with microscopy (Claudi, et al., 2014), also 225 
envisaging potential combinations with partially automated microscopy (like the Opera Phenix) to 
determine and visualize the distribution of bacteria with different division history in the organs 
(Figure 1, bottom left panel).  
One of the main limitations of FD is the number of generations that can be followed over time (6 to 
10 generations), as the signal decrease rapidly with a small number of bacterial generations; the latter 230 
is efficiently overcome with TIMER approaches that rely on expression under promoters highly active 
in vivo (Rollenhagen, et al., 2004). However, a different limitation of TIMER is the fact that 
maturation kinetics of the fluorescent reporters depend on oxygen partial pressure (Claudi, et al., 
2014), potentially limiting the use of the technique to study bacterial dynamics in homogeneously 
oxygenated tissues such as the spleen. 235 
 
4. The importance of mathematical modelling  
One attraction of the experimental methods outlined above is that they can produce simple semi-
quantitative patterns that can be intuitively interpreted (Crimmins and Isberg, 2012). For example, a 
loss of ITS diversity is the signature of a bottleneck; using FD, a subset of bacteria with constant 240 
fluorescence intensity represents persister cells. Essentially, ITS are reporters of bacterial mortality 
and migration, whereas FD and TIMER are markers of bacterial replication. During the course of 
infection however, all three processes occur simultaneously and vary in different ways within and 
between organs and in response to treatments. Hence simple data analysis is not sufficient to 
disentangle these processes: mathematical models are necessary to obtain the full picture (Vlazaki et 245 
al., 2019). Here we outline the use of models for ITS studies, but it is worth noting that similar 
methods can be applied to FD experimental data. 
Mathematical models simulate the growth, death and within-host migration of bacteria, generating 
synthetic data that can be directly compared to experimental datasets. Statistical tools can then be 
used to “fit” the model to data, which means estimating the values of unknown parameters (division 250 
rates, death rates, migration rates) that minimise the difference between the synthetic data and a given 
experimental dataset. Technically, this can be done using maximum likelihood (Coward et al., 2014, 
Kaiser et al., 2013), Bayesian inference (Dybowski et al., 2015) or minimisation of Kullback-Leibler 
divergence (Price et al., 2017).  
Importantly, those models do not simulate immune dynamics or antibiotic pharmacokinetics, as those 255 
variables are rarely measured in experimental infections. Instead, the models allow to estimate the 
impact of immunity or drugs on the division and survival rates of bacteria, by comparing the values 
between experimental groups or between time points.  For example, it was shown that a combination 
of bacterial death and rapid replication leads to the colonisation of the liver and spleen by independent 
bacterial subpopulations in the systemic phase of Salmonella infections (Grant et al., 2008), while the 260 
gut-lymphoid tissue interface was found to act as a major bottleneck in the enteric phase due to the 
low chance of bacteria migrating from the gut to the caecal lymph node (Kaiser et al., 2013). 
Individual components of the host immune system have also been identified as key players in the 
early dynamics of infection through comparison of the killing rates between immunocompetent mice 
and gene-targeted mutant mice lacking specific immunological pathways (Kaiser et al. 2013; Grant 265 
et al., 2008; Coward et al., 2014).  
Beyond exploratory research to characterise previously unchartered territories, other studies have 
used mathematical modelling integrated with experimental data to compare the dynamics between 
differentially treated groups. For instance, a comparison between the effects of different vaccine 
formulations on the within-host dynamics of S. enterica has been enabled through mathematical 270 
inference and quantification of the underlying dynamics (Coward et al., 2014), while comparing the 
dynamics of in vivo adapted versus culture-harvested bacteria revealed that the former grow faster as 
a result of lower death rates compared to culture-harvested bacteria (Dybowski et al., 2015). These 
models are stochastic, representing whole numbers of bacteria undergoing bottlenecks that can 
randomly wipe out some ITS and allow other to grow back, mimicking the random variations 275 
observed across replicates in the experiments (Grant, et al., 2008). In addition, different sources of 
measurement noise and error (e.g. due to finite sample sizes or cut-off points for quantitative PCR) 
can be included in the model, ensuring that parameter estimates are produced with reliable confidence 
intervals (Coward, et al., 2014, Price, et al., 2017). Unfortunately, the in vivo studies published so far 
have only used mathematical models to address the very early dynamics of infection. This pattern is 280 
not due to the lack of interest for the subsequent stages of the infection; it is the byproduct of 
computational limitations inherent in the likelihood inferential framework when applied to complex 
multiparametric systems evolving over longer time periods. These technical obstacles can be 
overcome with the development of computationally efficient tools like the moments-based, 
divergence minimisation approach (Price et al., 2017). 285 
Finally, mathematical models could be helpful not only to analyse the data generated experimentally, 
but also to optimise the design of future experiments that can be carried out in a more rational and 
cost-efficient way, or to validate the mathematical model itself. For example, based on model 
predictions, unlikely scenarios can be discarded a priori and research can delve on plausible 
hypotheses; numbers of experimental animals, experimental interventions and measured variables 290 
can be decided in line with post-experimental data analysis. Full implementation of proper 
mathematical models ultimately should reduce animal experimentation and allow in silico 
determination of treatments’ output. 
 
5. Population dynamics and infection process. 295 
The techniques and approaches described above are tools to study in vivo infections. Below we will 
delve on some areas of infection biology that have benefitted from the multidisciplinary integration 
of these techniques and approaches. We will briefly illustrate some representative examples of 
findings that would have been otherwise impossible to achieve with compartmentalized research. 
 300 
5.1 Understanding spread and distribution of the infection.  
Salmonella causing invasive diseases (like invasive non-typhoidal salmonellosis or typhoid fever) 
invade the gut and reach the bloodstream, with a proportion of the bacteria passing through the 
mesenteric lymph nodes (MLNs) (Carter and Collins, 1974). Lymph nodes are central in the process, 
with speed of onset of infection in various organs being different (Awofisayo-Okuyelu et al., 2019). 305 
Experimental infections of mice with a discrete number of ITS have revealed that the population 
structure present in the lymphatic compartment throughout the infection is markedly different from 
the one present in other systemic organs (e.g. spleen and liver have common population structure); 
thus MLNs are a separate compartment within the complexity of a multiorgan mammalian host 
(Rossi, et al., 2017). In blood, bacteria can be found either extracellularly or associated with 310 
leukocytes (Vazquez-Torres et al., 1999). From blood, bacteria reach the liver, spleen and bone 
marrow where they infect resident phagocytes (principally red pulp and marginal zone macrophages 
in the spleen and Kupffer cells in the liver (Richter-Dahlfors et al., 1997, Salcedo et al., 2001)). 
Confocal microscopy reveals that the infection begins at an intracellular density of one bacterium per 
host cell; then inflammatory mononuclear cells are recruited to the sites of infection with the 315 
formation of multicellular pathological lesions that trap the bacteria within discrete foci, surrounded 
by normal tissue (Richter-Dahlfors et al., 1997). This process is mediated by cytokines and adhesion 
molecules, with TNF-α being crucial, as its absence results in the lack of formation or regression of 
multicellular pathological lesion and causes recrudescence of the infection (Clare et al., 2003, Everest 
et al., 1998, Mastroeni et al., 1991, Mastroeni et al., 1995, Mastroeni et al., 1992, Mastroeni et al., 320 
1993, Rossi et al., 2017, Withanage et al., 2005). Cytokine networks are also essential for the 
activation of the recruited cells and for the expression of their antimicrobial activity (Mastroeni et al., 
1999, Mastroeni et al., 1996, Mastroeni et al., 1998, Muotiala and Makela, 1990). Within multicellular 
pathological lesions reactive oxygen and nitrogen species (ROS and RNS) restrict intracellular 
growth (Grant, et al., 2008, Mastroeni et al., 2000, Vazquez-Torres et al., 2000, Vazquez-Torres et 325 
al., 2000). The kinetics of intracellular growth is dependent upon the balance between host-resistance 
function/genetics and the virulence of the bacterial strain (Mastroeni and Grant, 2013). 
One of the key features of the spread and distribution of Salmonella in tissues, revealed by 
fluorescence microscopy approaches, is represented by low intracellular numbers of bacteria per 
infected cells regardless of the net growth rate of the bacteria. Growth of the bacteria in the tissues is 330 
paralleled by an increase in the number of infected cells and multicellular pathological lesions and 
not by a substantial increase in the intracellular number of bacteria within each infected host cells. 
The intracellular densities of Salmonella in the organs follow a Poisson distribution skewed towards 
low numbers underpinned by bacterial escape from infected phagocytes and dissemination to 
uninfected cells to form new infection foci (Sheppard, et al., 2003). Reinfection events occur at a very 335 
low rate (<1%) (Gog et al., 2012) and new foci of infection are largely clonal (Sheppard, et al., 2003). 
Bacteria with disabling mutations in genes of the Salmonella pathogenicity island-2 (SPI-2) encoded 
Type III secretion system are impaired in tissue spread and accumulate intracellularly within few cells 
(Grant, et al., 2012). 
During the extracellular phase Salmonella become vulnerable to antibodies and complement (Rossi 340 
et al., 2019) that opsonise the bacteria and target them to receptors on the surface of phagocytes 
increasing the ROS-dependent antimicrobial functions of these cells (Liang-Takasaki et al., 1983, 
Mastroeni and Grant, 2013).  
Performing infections of the mouse with low numbers of ITS, it has been possible to outline the 
whole-body dynamics in the early stages of systemic disease.  In the initial phase of infection (first 6 345 
hours after inoculation), concomitant death and rapid bacterial replication leads to the establishment 
of independent bacterial subpopulations in different organs that spread only locally. The 
subpopulation structure (presence and relative proportion of individual ITS in each organ) remains 
different in different organs up to 24 hours post infection (Grant, et al., 2008). This is an intriguing 
finding; in fact, early in infection the bacteria spread from cell to cell at distant sites in each organ, 350 
but their spread appears to be confined to the boundaries of a particular organ or tissue.  With the 
progression of the infection, decreased microbial mortality leads to an exponential increase in the 
number of bacteria within the spleen and liver, that is paralleled by the spread of the microorganisms 
throughout the body via blood and establishment of new infection foci, with the mixing of bacteria 
between organs via bacteraemia and further stochastic selection (Grant, et al., 2008). 355 
The combination of ITS and gene targeted immune-deficient mice has added an additional layer of 
resolution to the study of the interactions between bacteria and the host. This approach has allowed 
to interrogate the precise function of individual elements of the immune response on the growth, death 
and spread of the infection. For example, the use of ITS in mice lacking the gp19 subunit of the 
phagocyte NADPH oxidase conclusively established the bactericidal activity of reactive oxygen 360 
metabolites on intracellular Salmonella in vivo (Grant, et al., 2008). With the use of FD, replication 
has been directly quantified, and the role of SPI-2 T3SS has been shown mainly in fostering bacterial 
replication, but not in avoidance of killing by macrophages. FD was also used to understand that 
nonreplicating bacterial cells are generated immediately after uptake by macrophages; in fact the 
vacuolar acidification and nutritional deprivation within SCV induce gene expression in the bacteria 365 
with activation of several toxin-antitoxin modules, the creation of phenotypic heterogeneity and 
formation of persistor cells acting as reservoir for infections able to resume their division when 
environmental conditions becomes more favourable (Helaine, et al., 2014, Helaine, et al., 2010).  
In conclusion, combining multidisciplinary approaches can reveal the true dynamics of the infection 
process. These approaches include acquisition of distributional data obtained from the direct 370 
observation of bacterial populations in tissues by microscopy, the use of isogenic tagged strains, 
mathematical modelling, fluorescent reporters of bacterial division history, immunological single cell 
techniques such as flow cytometry, and transcriptomic profiling of tissues and single cells. 
 
5.2. Population dynamics and antimicrobial treatment 375 
Currently, little is known about how antibiotics act in vivo at the level of individual bacteria and 
individual organs/host cells. This is a neglected area of in vivo infection biology that will require 
interdisciplinary and comprehensive efforts and dedicated funding.  
Intense research efforts have focussed on the prevalence and spread of antimicrobial resistance 
(AMR) genes/phenotypes in microbial species. However, difficulties in treating bacterial infections 380 
cannot always be ascribed to pathogens carrying antimicrobial resistance genes. Treatment of an 
infection with antibiotics does not always result in the rapid and complete elimination of the pathogen 
from the tissues even when the bacteria are highly susceptible to the drug in vitro.  
When Salmonella systemic infections are treated with antimicrobials such as beta-lactams or 
fluoroquinolones a bi-phasic reduction in bacterial numbers is observed with an initial rapid decrease 385 
in the bacteria load followed by a phase of slower reduction in bacterial numbers (Claudi, et al., 2014, 
Kaiser, et al., 2013, Rossi, et al., 2017). This is often followed by a third phase where the number of 
culturable bacteria remains constant in the tissues despite the prolongation of the treatment and the 
fact that these persisting bacteria retain susceptibility to the drug. In fact, when bacteria are isolated 
and cultured from animal tissues during and/or after antibiotic treatment, they do not show a decrease 390 
in antibiotic sensitivity in vitro (as measured by the MIC [Minimum Inhibitory Concentration]). 
The persistence of antimicrobial-sensitive bacteria during and after treatment is a problem of great 
medical importance as it can lead to chronic infections, emergence of antimicrobial resistant 
populations, prolonged transmission, within-host bacterial evolution and dangerous relapses 
especially in immune-deficient individuals (Crump et al., 2004, Gordon, 2011, Klemm et al., 2016, 395 
Okoro et al., 2012). Notably, persistence of non-AMR resistant bacterial population occurs even in 
the presence of an  intact immune system (Casadevall and Pirofski, 2000, Gordon et al., 2010, Kaiser, 
et al., 2013, Klemm et al., 2016, Mc, 1958, Okoro, et al., 2012). Currently, the efficacy of a particular 
treatment is still difficult predict a priori and there is no guarantee that an individual is going to clear 
the infection after a course of antimicrobials.  400 
The reasons for discrepancies between the efficacy of some antibiotics in vitro and poor outcome of 
treatment in vivo are difficult to explain using traditional pharmacokinetic and pharmacodynamics 
parameters. Methods that capture the replicative status and location of different bacterial 
subpopulations within organs and tissues as well as the immunological status of the host allow 
consideration of key variables within the links between treatment and outcome of an infection (Grant 405 
et al., 2009, Grant, et al., 2008, Sheppard, et al., 2003).  
 
5.3 Replicative status and heterogeneity 
Subpopulations of bacteria have extensive phenotypic variation in in vivo fission rates, ranging from 
fast division to a non-replicating intracellular status within phagocytes. Therefore, studying the 410 
correlations between growth rates and antibiotic treatment is important to understand the efficacy of 
antimicrobial treatments as well as why and where bacteria may persist in the tissues. As briefly 
mentioned above, studies in mice revealed that slowly-replicating bacterial populations are less 
susceptible to antimicrobials; these non-replicating bacteria can be completely refractory to treatment 
but can resume growth in the absence of antimicrobial exposure (Claudi, et al., 2014, Gordon, et al., 415 
2010, Helaine, et al., 2014, Helaine and Holden, 2013, Helaine, et al., 2010, Klemm, et al., 2016, 
Maskell and Hormaeche, 1985, Maskell and Hormaeche, 1986, Okoro, et al., 2012). Slow-growing 
bacterial subpopulations can have a selective advantage under antimicrobial pressure (Claudi, et al., 
2014, Helaine, et al., 2014) and prolonged treatment with antimicrobials can kill up to 99% of bacteria 
from the tissues leaving a residual microbial load that is able to cause relapse (Bonina et al., 1990, 420 
Maskell and Hormaeche, 1985).  
Using integrated techniques such as use of fluorescent bacterial strains, microscopy and a 
mathematical analysis, it has been observed that during systemic infections bacterial populations 
undergo a phenotypic switch to enter into a slow-growing or growth-arrested phase which is 
phenotypically tolerant to antimicrobial action (Balaban et al., 2004, Kussell and Leibler, 2005). This 425 
phenotypic divergence has been observed by using fluorescent intracellular growth reporters that are 
diluted in the bacterial cytoplasm at every division (Fisher et al., 2017); almost all bacteria extracted 
form MLNs after multiple days of treatment retained very high fluorescence levels (e.g. similar to the 
fluorescence level detected at the beginning of the experiment), indicating that the subpopulations of 
Salmonella capable of surviving treatment in mice undergo none or very few cell divisions (Helaine, 430 
et al., 2014). A similar behaviour was confirmed in spleen with fast-growing Salmonella 
subpopulations being extensively killed and slow growing bacteria surviving the treatment (Claudi, 
et al., 2014). 
Toxin-antitoxin modules, stress responses, host cell microenvironment, and nutrient deprivation, are 
mechanisms involved in the formation of persisters (Claudi, et al., 2014, Helaine, et al., 2014). 435 
Intriguingly, persisting bacteria that resist to antibiotics still retain the ability to transcribe, translate 
and translocate SPI-2 virulence effectors in a non-growing state, when internalized in macrophages; 
this enables the reprogramming of host cells from a M1-like pro-inflammatory bactericidal state to a 
M2-like anti-inflammatory permissive state, a critical step for persisters to survive long term in 
macrophages (Pham et al., 2020). It has also been shown using a combination of flow cytometry, 440 
fluorescence microscopy and RNA seq that non-growing persisters use the effector SteE from the 
SPI-2 T3SS to direct macrophages to the M2 state to allow them to persist and remain tolerant to 
antimicrobials(Stapels, et al., 2018).  
The dynamics of bacterial persistence are different in different organs and tissues. Salmonella can be 
detected in spleens, livers and MLNs organs of mice for more than 10 days post-infection and 445 
antimicrobial treatment. MLNs are a peculiar niche for persistence (Griffin et al., 2011, Kaiser et al., 
2014, Rossi, et al., 2017). In fact, a reduction in viable bacterial numbers is not obvious in MLN as a 
consequence antimicrobial treatment. The overall bacterial load in these tissues is not affected by 
antimicrobial treatment (Claudi, et al., 2014, Rossi, et al., 2017). Other studies also indicate that 
bacteria in the MLNs are lest affected by antibiotic treatment compared to those residing in other 450 
tissues. In fact, bacteria become largely undetectable within a few days of exposure to antimicrobials 
by direct in vivo imaging of Salmonella lux positive, and MLNs remain the final organ to display a 
detectable signal of infection (Griffin, et al., 2011). Consistently, following antimicrobial cessation, 
the earliest detection of bacteria also occurred in MLNs (hence a site of rapid relapse), with bacterial 
growth eventually progressing to include multiple systemic tissues, most notably the spleen and liver.  455 
Cessation of treatment results either in the relapse of the infection or in prolonged persistence of the 
bacteria in defined niches, depending on host genetics and/or the virulence of the bacterial strain. In 
situations where genetically susceptible experimental animals are infected with virulent bacteria the 
infection relapses promptly if treatment is withdrawn and the rate of net bacterial growth in the post-
treatment phase is very similar to that of the pre-treatment phase. In this experimental setup, relapse 460 
can be avoided only if treatment is prolonged, presumably until the onset of acquired immunity in the 
host (Maskell and Hormaeche, 1985, Maskell and Hormaeche, 1986, Rossi, et al., 2017). Post-
antibiotic persistence and relapses of Salmonella infections have also been described in humans, 
especially in patients with immune-deficiencies (Gordon, et al., 2010, Klemm, et al., 2016, Okoro, et 
al., 2012).  465 
The use of ITS in experimental systemic infections (Kaiser, et al., 2013, Rossi, et al., 2017) has 
allowed to study the subpopulation dynamics of a Salmonella infection during the treatment and 
relapse phase. It has become clear that the population heterogeneity of the bacteria load is not reduced 
during treatment indicating that the antibiotic does not select for one of few clones within the bacterial 
load. Furthermore, no preferential amplification of any of the ITS can be detected during the relapse 470 
phase, further indication that relapse does not originate from a restricted number of subpopulations 
that has been preferentially selected by the antibiotic treatment. Chronic and relapsing infections also 
arose evenly from the persistence of multiple subpopulations of Salmonella. (Rossi, et al., 2017).  
 
5.4 Location and the immune system 475 
Host immunity can potentially exert opposing effects on the efficacy of antibiotic treatment. On one 
side it co-operates with antimicrobials by eliminating bacteria from the tissues and preventing the 
relapse of the infection. On the other, hand immunity can limit the efficacy of antimicrobials by 
creating environments hostile to their penetration and efficacy (e.g. granulomas). Furthermore, 
phagocyte activation can determine a reduction in bacterial division rates and can activate MDR 480 
pumps, thus reducing susceptibility to many antimicrobials (references).  
Granulomas can represent sites where antibiotics penetrate poorly and could therefore enable 
bacterial persistence during the course of treatment, with the use of microscopy and growth curves it 
has also been seen that cytokines such as TNFα are required for the formation of granulomas in many 
bacterial infections (Mastroeni, et al., 1995). Salmonella Typhimurum infected granulomas 485 
predominantly consist of macrophages, with a mixture of both M1 and M2 stages depicting both the 
protective nature of a granuloma to the host while potentially being permissive to persistence of the 
bacteria. (Pham, et al., 2020).  
Treating mice with anti-TNFα antibodies inhibits or reverses the formation of granulomas, and 
therefore could potentially enhance the efficacy of treatment against bacteria that localise within these 490 
pathological tissue lesions (Mastroeni, et al., 1995). However, as explained below, experimental 
evidence suggests that this may not be the case. In fact, anti-TNFα treatments in systemic murine 
Salmonella infection neither preclude nor enhance the efficacy of antimicrobial treatment, but 
dangerously leave the host prone to more severe relapses of the infection due to immunosuppression. 
Combinations of anti-cytokine compounds and antimicrobial molecules may therefore not be a useful 495 
approach to treat persistent infections with intracellular bacteria like Salmonella (Rossi, et al., 2017). 
To fully understand post-antibiotic persistence in vivo it is important to indentify the host cells 
associated with the microorganisms during and after antimicrobial treatment. Using GFP-expressing 
bacteria and flow cytometry recent studies have determined the main types of splenocytes where 
Salmonella in found in mice during and after ciprofloxacin treatment. Dendritic cells, macrophages 500 
and neutrophils were found to be the main cell populations associated with bacteria that persist after 
ciprofloxacin treatment. These data extend previous studies where neutrophils had been reported as 
a splenic "safe" site where Salmonella persists after treatment with gentamicin (antimicrobial acting 
mainly on extracellular bacteria) and where dendritic cells had been reported as a site of persistence 
in the MLNs of mice in an enteritis model (Kaiser, et al., 2013, Rossi, et al., 2017).  505 
Upon cessation of antibiotic treatment, the expected relapse of the infection leads to the major cell 
types associated with Salmonella differing from the pre-treatment phase. In fact, upon re-growth in 
vivo, the bacteria did not re-populate spleen cells in the same proportions as in the pre-antibiotic phase 
(Kanvatirth et al., 2020). These data show that the cellular dynamics of the infection in the pre-
antibiotic phase are different from the relapse phase.  510 
The role of host cell populations in modulation the efficacy of antibiotics can be studied by depleting 
individual host cell types during treatment of an infection. In murine Salmonella infections, host cell 
depletion experiments revealed a dichotomous role of immune cell populations in the clearance or 
persistence of Salmonella during antimicrobial treatment (Kanvatirth, et al., 2020). In vivo depletion 
of PMNs resulted in higher bacterial numbers in the spleen at the end of treatment, consistent with 515 
the fact that PMNs are one of the cells principally involved in innate immunity to Salmonella and are 
efficient producers of ROS. While, depletion of macrophages and dendritic cells had a beneficial 
effect on the antimicrobial treatment, resulting in lower bacterial numbers in the spleen. Therefore, 
cell populations that are crucial to the control of the infection in the phase of innate immunity and 
that are involved in antigen presentation and generating an adaptive response are also responsible for 520 
carriage of the residual bacterial population after ciprofloxacin treatment. There is potential that by 
immune-modulatory treatments (Kanvatirth, et al., 2020, Kaufmann et al., 2017) and exploring 
unexploited enzymes as targets for antimicrobials  (Becker et al., 2006) could improve the treatment 
of a systemic Salmonella infection.  
 525 
5.5 Population dynamics after vaccination 
The use of appropriate methods to understand the pathogenesis and in vivo infection dynamics is 
crucially important in the rational design of vaccination strategies and in the understanding of their 
potential impact on the infection process.  
The dispersive nature of infection caused by Salmonella has profound implications for understanding 530 
the immunological requirements of vaccine-mediated protective immunity. During the intracellular 
phase of growth/persistence it is plausible to postulate that immunity produced through vaccination 
needs to potentiate the antimicrobial action of phagocytes by Th1 type T-cell immunity. In contrast, 
during the extracellular phase, bacteria are vulnerable to antibody-mediated complement killing 
(serum bactericidal activity) (Micoli et al., 2018) and cell-mediated killing (opsonophagocytosis) 535 
(Ramachandran et al., 2016). The relative importance of these two antibody-mediated killing 
mechanisms in vivo varies, and it is likely to be dependent on the bacterial strain and the anatomical 
compartment where the bacteria are located, as well as on the relative abundance and qualitative traits 
(e.g. isotypes, affinity, FcR usage and complement activation) of antibodies (Rossi, et al., 2019). (Goh 
et al., 2011, Goh et al., 2016, Gondwe et al., 2010, MacLennan et al., 2008).  540 
The combination of in vivo measurements in overall bacterial numbers combined with tracking of 
ITS and mathematical modelling has allowed an insight into how different classes of vaccines and 
branches of the immune response protect against secondary Salmonella enterica infections in mice 
(Coward, et al., 2014). These studies revealed that live attenuated Salmonella vaccines significantly 
reduce bacteraemia during a secondary challenge and can contain the growth and spread of the 545 
bacteria in systemic organs. Live vaccine immunisation enhances both the bacterial killing in the very 
early stages of the infection and the bacteriostatic control over the first day post-challenge. In contrast 
non-living vaccines, while able to enhance initial blood clearance and killing of virulent bacteria, do 
not alter the subsequent bacterial growth rate in the systemic organs, do not prevent the resurgence 
of bacteraemia, and fail to control the spread of the bacteria in the body (Coward, et al., 2014).  550 
The experimental evidence that during a systemic secondary infection antibodies alone, without T 
cellular immunity, cannot control bacterial growth, spread and bacteraemia, provides an explanation 
for the high incidence and recurrence of systemic salmonellosis in individuals where co-morbidities 
such as malaria and HIV impair cell-mediated immunity (T-cells and phagocytes) (Mastroeni and 
Rossi, 2016). 555 
Vaccination can also affect the occurrence of persisters in vivo. Vaccination of mice with killed S. 
Typhimurium results in a reduction in bacterial persisters of about 500-fold as compared to naïve 
mice upon secondary infection and ciprofloxacin/ampicillin treatment. Furthermore, vaccination 
prevents the transfer of transconjugants, hence suggesting a central role that vaccines may have not 
only to protect against infections, but also to prevent the spread of anti microbial resistance (AMR) 560 
(Bakkeren et al., 2019). 
 
6. Conclusion and perspectives 
Understanding the in vivo dynamics of bacterial persistence at the single cell level during 
antimicrobial treatment and the niches where persistent bacteria reside after therapy is of paramount 565 
importance for developing targeted medical and veterinary treatments complementary or alternative 
to classical antimicrobial treatment based on manipulation of the host (Czaplewski et al., 2016, 
Hancock et al., 2012). This is crucial considering the slow progress in current pipelines for discovery 
of new antimicrobial molecules (Lewis, 2013). These will include designing host-cell specific 
immunological approaches, as shown by the different effects of cell-depletions in vivo, or in the future 570 
delivering drugs “in situ” at the infection foci to the right cells where persistent bacteria are found. 
This will maximise the therapeutic potential of currently available antimicrobials and will inform 
about the requirement for new drugs and new targeted delivery systems (Kaufmann, et al., 2017, 
Lewis, 2013). Similarly, an in-depth understanding of the mechanism of action of vaccines and 
antibodies induced on the bacterial subpopulations will allow the maximisation and the design of 575 
vaccines that would target specific cell types, with the right antigen and the right adjuvant for each 
specific site. 
All the above can truly be performed only by maximising and integrating all the information that is 
available with sophisticated techniques described in this review both at the single-cell and whole 
organism level. 580 
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